Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A previously reported randomized clinical trial showed treatment of Bowen's disease using photodynamic therapy (PDT) with topically applied delta-aminolaevulinic acid (ALA) to be at least as effective as cryosurgery and to be associated with fewer adverse effects. OBJECTIVES: To compare ALA-PDT and cryotherapy in the treatment of histopathologically verified basal cell carcinomas (BCCs) in a non-blinded, prospective phase III clinical trial. METHODS: One lesion from each of 88 patients was included. The BCCs were divided into superficial and nodular lesions. The follow-up period was restricted to 1 year with close follow-up for the first 3 months. Efficacy was assessed as the recurrence rate 12 months after the first treatment session, verified by histopathology. Tolerability was evaluated as the time of healing, pain and discomfort during and after the treatment, and final cosmetic outcome. RESULTS: Histopathologically verified recurrence rates in the two groups were statistically comparable and were 25% (11 of 44) for ALA-PDT and 15% (six of 39) for cryosurgery. However, clinical recurrence rates were only 5% (two of 44) for PDT and 13% (five of 39) for cryosurgery. Additional treatments, usually one, had to be performed in 30% of the lesions in the PDT group. The healing time was considerably shorter and the cosmetic outcome significantly better with PDT. Pain and discomfort during the treatment session and in the following week were low, and were equivalent with the two treatment modalities. CONCLUSIONS: In terms of efficacy, ALA-PDT is comparable with cryosurgery as a treatment modality for BCCs. Retreatments are more often required with PDT than with cryosurgery. This can easily be performed due to the shorter healing time, less scarring and better cosmetic outcome that follows ALA-PDT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509
Kennedy (1992) · doi:10.1016/1011-1344(92)85108-7 · Cited by 1,166
ROWE, D. E., CARROLL, R. J., & JR. DAY, C. L. (1989) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1989.tb03166.x · Cited by 802
Metastatic basal cell carcinoma
Domarus, H. V., & Stevens, P. J. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80334-5 · Cited by 534
SVANBERG, K., ANDERSSON, T., KILLANDER, D., WANG, I., STENRAM, U., ANDERSSON-ENGELS, S., BERG, R., JOHANSSON, J., & SVANBERG, S. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb03412.x · Cited by 418
Self-citationPhotodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells.
Agarwal, M. L., Clay, M. E., Harvey, E. J., Evans, H. H., Antunez, A. R., & Oleinick, N. L. (1991) · PubMed · Cited by 411
Regula, J., MacRobert, A. J., Gorchein, A., Buonaccorsi, G. A., Thorpe, S. M., Spencer, G. M., Hatfield, A. R., & Bown, S. G. (1995) · Gut · doi:10.1136/gut.36.1.67 · Cited by 354
Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid
Wolf, P., Rieger, E., & Kerl, H. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70002-b · Cited by 341
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease
MORTON, C. A., WHITEHURST, C., MOSELEY, H., MCCOLL, J. H., MOORE, J. V., & MACKIE, R. M. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1076.x · Cited by 306
Calzavara-Pinton, P. (1995) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(95)07106-c · Cited by 266
Induction of Tumor Immunity by Photodynamic Therapy
KORBELIK, M. (1996) · Journal of Clinical Laser Medicine & Surgery · doi:10.1089/clm.1996.14.329 · Cited by 256
Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
Van Hillegersberg, R., Van Den Berg, J. W. O., Kort, W. J., Terpstra, O. T., & Wilson, J. H. P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90860-2 · Cited by 198
Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery
HOLT, P. J. A. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb03205.x · Cited by 172
Porphyrin metabolism in some malignant diseases
el-Sharabasy, M., el-Waseef, A., Hafez, M., & Salim, S. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.83 · Cited by 150
Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase
Dailey, H. A., & Smith, A. (1984) · Biochemical Journal · doi:10.1042/bj2230441 · Cited by 140
An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo
Webber, J. D., Luo, Y., Crilly, R., Fromm, D., & Kessel, D. H. (1996) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(96)07291-0 · Cited by 92
Wennberg, A., Lindholm, L.-E., Alpsten, M., & Larkö, O. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505256 · Cited by 89
af Klinteberg, C., Enejder, A. M. K., Wang, I., Andersson‐Engels, S., Svanberg, S. R., & Svanberg, K. (1999) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(99)00045-7 · Cited by 84
Self-citationWang, I., Bauer, B., Andersson‐Engels, S., Svanberg, S., & Svanberg, K. (1999) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1999.770213.x · Cited by 83
Self-citationHeyerdahl, H., Wang, I., Liu, D. L., Berg, R., Andersson‐Engels, S., Peng, Q., Moan, J. E., Svanberg, S. R., & Svanberg, K. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04576-4 · Cited by 73
Self-citationPhotodynamic and photohyperthermic response of malignant tumors
Svaasand, L. O. (1985) · Medical Physics · doi:10.1118/1.595671 · Cited by 63
Leibovici, L., Schoenfeld, N., Yehoshua, H., Mamet, R., Rakowsky, E., Shindel, A., & Atsmon, A. (1988) · Cancer · doi:10.1002/1097-0142(19881201)62:11<2297::aid-cncr2820621106>3.0.co;2-7 · Cited by 61
Andersson‐Engels, S., Berg, R., Svanberg, K., & Svanberg, S. R. (1995) · Bioimaging · doi:10.1002/1361-6374(199509)3:3<134::aid-bio4>3.0.co;2-1 · Cited by 43
Self-citationThe treatment of basal cell carcinoma by radiotherapy.
Orton, C. I. (1978) · PubMed · Cited by 35
Statistical Data on Malignant Tumors in Cryosurgery: 1982
Graham, G. F. (1983) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1983.tb00795.x · Cited by 32
Electrocoagulation for skin cancer: An old oncologic tool revisited
Whelan, C. S., & Deckers, P. J. (1981) · Cancer · doi:10.1002/1097-0142(19810501)47:9<2280::aid-cncr2820470930>3.0.co;2-u · Cited by 26
5-Aminolevulinic acid-based photodynamic therapy
(1997) · doi:10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o
Cited by
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
“Barrett esophagus and various grades of dysplasia and early esophageal cancer are the best-studied PDT applications in the GI tract.(194,195) Premalignant conditions such as Barrett esophagus with high-grade dysplasia are theoretically ideal for PDT.”
BackgroundClinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
The present and future role of photodynamic therapy in cancer treatment
Brown, S. B., Brown, E. A., & Walker, I. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01529-3 · Cited by 1,771
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Photosensitizers in clinical PDT
Allison, R. R., Downie, G. H., Cuenca, R., Hu, X.-H., Childs, C. J., & Sibata, C. H. (2004) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(04)00007-9 · Cited by 1,059
Metadata
- Authors
- Wang, I., Bendsoe, N., Klinteberg, C. A., Enejder, A. M. K., Andersson-Engels, S., Svanberg, S., & Svanberg, K.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04
- Volume
- 144
- Issue
- 4
- Pages
- 832-840
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2119492226
- Cited by
- 309
- References
- 27
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.